Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 199

1.

Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits.

Pradilla G, Thai QA, Legnani FG, Hsu W, Kretzer RM, Wang PP, Tamargo RJ.

Neurosurgery. 2004 Dec;55(6):1393-9; discussion 1399-1400.

PMID:
15574221
[PubMed - indexed for MEDLINE]
2.

Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats.

Gabikian P, Clatterbuck RE, Eberhart CG, Tyler BM, Tierney TS, Tamargo RJ.

Stroke. 2002 Nov;33(11):2681-6.

PMID:
12411661
[PubMed - indexed for MEDLINE]
Free Article
3.

Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage.

Momin EN, Schwab KE, Chaichana KL, Miller-Lotan R, Levy AP, Tamargo RJ.

Neurosurgery. 2009 Nov;65(5):937-45; discussion 945. doi: 10.1227/01.NEU.0000356974.14230.B8.

PMID:
19834407
[PubMed - indexed for MEDLINE]
4.

Local delivery of ibuprofen via controlled-release polymers prevents angiographic vasospasm in a monkey model of subarachnoid hemorrhage.

Pradilla G, Thai QA, Legnani FG, Clatterbuck RE, Gailloud P, Murphy KP, Tamargo RJ.

Neurosurgery. 2005 Jul;57(1 Suppl):184-90; discussion 184-90.

PMID:
15987587
[PubMed - indexed for MEDLINE]
5.

Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage.

Frazier JL, Pradilla G, Wang PP, Tamargo RJ.

J Neurosurg. 2004 Jul;101(1):93-8.

PMID:
15255257
[PubMed - indexed for MEDLINE]
6.

Controlled release of lipopolysaccharide in the subarachnoid space of rabbits induces chronic vasospasm in the absence of blood.

Recinos PF, Pradilla G, Thai QA, Perez M, Hdeib AM, Tamargo RJ.

Surg Neurol. 2006 Nov;66(5):463-9; discussion 469.

PMID:
17084186
[PubMed - indexed for MEDLINE]
7.

Prevention and reversal of experimental posthemorrhagic vasospasm by the periadventitial administration of nitric oxide from a controlled-release polymer.

Tierney TS, Clatterbuck RE, Lawson C, Thai QA, Rhines LD, Tamargo RJ.

Neurosurgery. 2001 Oct;49(4):945-51; discussion 951-3.

PMID:
11564257
[PubMed - indexed for MEDLINE]
8.

Intracranial delivery of the nitric oxide donor diethylenetriamine/nitric oxide from a controlled-release polymer: toxicity in cynomolgus monkeys.

Tierney TS, Pradilla G, Wang PP, Clatterbuck RE, Tamargo RJ.

Neurosurgery. 2006 May;58(5):952-60; discussion 952-60.

PMID:
16639332
[PubMed - indexed for MEDLINE]
9.

Effects of a nitric oxide donor on and correlation of changes in cyclic nucleotide levels with experimental vasospasm.

Aihara Y, Jahromi BS, Yassari R, Sayama T, Macdonald RL.

Neurosurgery. 2003 Mar;52(3):661-7; discussion 666-7.

PMID:
12590692
[PubMed - indexed for MEDLINE]
10.

Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates.

Clatterbuck RE, Gailloud P, Tierney T, Clatterbuck VM, Murphy KJ, Tamargo RJ.

J Neurosurg. 2005 Oct;103(4):745-51.

PMID:
16266059
[PubMed - indexed for MEDLINE]
11.
12.

Prevention of cerebral vasospasm by local delivery of cromakalim with a biodegradable controlled-release system in a rat model of subarachnoid hemorrhage.

Omeis I, Chen W, Jhanwar-Uniyal M, Rozental R, Murali R, Abrahams JM.

J Neurosurg. 2009 May;110(5):1015-20. doi: 10.3171/2008.8.JNS08202.

PMID:
19119878
[PubMed - indexed for MEDLINE]
13.

Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.

Wolf EW, Banerjee A, Soble-Smith J, Dohan FC Jr, White RP, Robertson JT.

J Neurosurg. 1998 Aug;89(2):279-88.

PMID:
9688124
[PubMed - indexed for MEDLINE]
14.

The intracerebral administration of phenytoin using controlled-release polymers reduces experimental seizures in rats.

Tamargo RJ, Rossell LA, Kossoff EH, Tyler BM, Ewend MG, Aryanpur JJ.

Epilepsy Res. 2002 Feb;48(3):145-55.

PMID:
11904233
[PubMed - indexed for MEDLINE]
15.

Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo.

Marbacher S, Neuschmelting V, Graupner T, Jakob SM, Fandino J.

Intensive Care Med. 2008 May;34(5):932-8. doi: 10.1007/s00134-008-0995-x. Epub 2008 Jan 24.

PMID:
18214428
[PubMed - indexed for MEDLINE]
16.

Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm.

McGirt MJ, Pradilla G, Legnani FG, Thai QA, Recinos PF, Tamargo RJ, Clatterbuck RE.

Neurosurgery. 2006 May;58(5):945-51; discussion 945-51.

PMID:
16639331
[PubMed - indexed for MEDLINE]
17.

Reversal of cerebral vasospasm by the nitric oxide donor SNAP in an experimental model of subarachnoid haemorrhage.

Kiriş T, Karasu A, Yavuz C, Erdem T, Unal F, Hepgül K, Baloğlu H.

Acta Neurochir (Wien). 1999;141(12):1323-8; discussion 1328-9.

PMID:
10672304
[PubMed - indexed for MEDLINE]
18.

Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.

Atalay B, Caner H, Cekinmez M, Ozen O, Celasun B, Altinors N.

Neurosurgery. 2006 Nov;59(5):1102-7; discussion 1107-8.

PMID:
17143244
[PubMed - indexed for MEDLINE]
19.

Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits.

Pradilla G, Wang PP, Legnani FG, Ogata L, Dietsch GN, Tamargo RJ.

J Neurosurg. 2004 Jul;101(1):88-92.

PMID:
15255256
[PubMed - indexed for MEDLINE]
20.

Caffeic acid phenethyl ester (CAPE) attenuates cerebral vasospasm after experimental subarachnoidal haemorrhage by increasing brain nitric oxide levels.

Aladag MA, Turkoz Y, Ozcan C, Sahna E, Parlakpinar H, Akpolat N, Cigremis Y.

Int J Dev Neurosci. 2006 Feb;24(1):9-14. Epub 2006 Jan 20.

PMID:
16427758
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk